No products in the cart.
New
Tirzepatide-60mg (5mL Vial)
$300.00
Tirzepatide is a groundbreaking synthetic polypeptide that stands out as a novel dual agonist for both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. This unique “twincretin” design, which incorporates 39 amino acids and a C20 fatty diacid moiety for extended action, allows Tirzepatide to mimic the actions of two distinct incretin hormones naturally secreted by the gut. Its prolonged half-life (approximately 5 days) is achieved through strong binding to plasma albumin and reduced renal clearance, enabling convenient once-weekly administration. This dual agonism confers a synergistic effect, offering superior efficacy in glycemic control and weight reduction compared to single-receptor agonists.
Description
Quick Facts
Tirzepatide 60mg (5mL Vial) is a premium research-grade peptide designed for advanced metabolic and endocrine studies. This synthetic dual receptor agonist targets glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, offering a unique tool for investigating glucose metabolism, insulin sensitivity, and appetite regulation. Supplied as a lyophilized powder, it requires reconstitution with bacteriostatic water (not included) and is strictly intended for laboratory use by qualified professionals.
Chemical Composition
Tirzepatide is a 39-amino acid synthetic peptide with a molecular formula of C225H348N48O68 and a molecular weight of 4813.52 g/mol. It features a C20 fatty diacid moiety conjugated via a hydrophilic linker, enhancing stability and extending its half-life. This structural design ensures consistent performance in preclinical research models, making it ideal for studying incretin hormone pathways.
Mechanism of Action
Tirzepatide acts as a dual GIP/GLP-1 receptor agonist, activating signaling cascades in tissues such as the pancreas, brain, gastrointestinal tract, and adipose tissue. It enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and modulates appetite, providing a synergistic effect on metabolic regulation. These properties make it a valuable compound for exploring type 2 diabetes, weight management, and cardiovascular health in controlled laboratory settings.
Product Specifications
- Purity: ≥99% (HPLC verified)
- Form: Lyophilized powder in a 5mL sterile vial
- Unit Size: 60mg per vial
- Storage: Store at -20°C or below, protected from light
- Usage: For in vitro laboratory research only; not for human or animal consumption
Research Applications
Tirzepatide 60mg is widely utilized in studies focusing on:
- Glucose metabolism and insulin sensitivity
- Appetite regulation and weight modulation
- Dual GIP/GLP-1 receptor signaling pathways
- Metabolic disorders, including type 2 diabetes Its high purity and stability make it suitable for precise, reproducible results in preclinical investigations.
Handling and Safety
This product is intended solely for laboratory research and must be handled by trained professionals in controlled settings. Reconstitute with 2.0mL bacteriostatic water for a concentration of 15mg/0.5mL. Avoid exposure to heat or moisture. Not approved for therapeutic, diagnostic, or consumptive use. Adhere to all safety protocols during handling.
Why Choose Tirzepatide 60mg?
Tirzepatide 60mg (5mL Vial) offers researchers a high-purity, reliable compound for cutting-edge metabolic studies. Its dual agonism and extended half-life provide a robust platform for exploring innovative treatments, making it an essential tool for advancing scientific discovery in metabolic and endocrine research.
⚠️ *Important Notice: All peptides are supplied in a powdered (lyophilized) form. They must be reconstituted before use.
